Misoprostol in the era of COVID-19: a love letter to the original medical abortion pill.

Jayaweera, Ruvani T; Moseson, Heidi; Gerdts, Caitlin

Jayaweera, Ruvani T; Moseson, Heidi; Gerdts, Caitlin.

Jayaweera RT; Senior Project Manager, Ibis Reproductive Health, Oakland, CA, USA; Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, USA.
Moseson H; Epidemiologist, Ibis Reproductive Health, Oakland, CA, USA.
Gerdts C; Vice-President for Research, Ibis Reproductive Health, Oakland, CA, USA.

Sex Reprod Health Matters ; 28(1): 1829406, 2020 12.

Article in English | MEDLINE | ID: covidwho-894521

Subject(s)

Abortifacient Agents, Nonsteroidal/administration & dosage; Abortion, Induced/statistics & numerical data; Betacoronavirus; Coronavirus Infections/epidemiology; Misoprostol/administration & dosage; Pneumonia, Viral/epidemiology; COVID-19; Female; Humans; Pandemics; Patient Acceptance of Health Care/statistics & numerical data; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2

Keywords

abortion; medical abortion; misoprostol; self-managed abortion

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Abortifacient Agents, Nonsteroidal / Misoprostol / Abortion, Induced / Coronavirus Infections / Betacoronavirus Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Pregnancy Language: English Journal: Sex Reprod Health Matters Year: 2020 Document Type: Article Affiliation country: 26410397.2020.1829406

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google